Grail rallies as FDA staff flags no major concerns for multi-cancer test

2

By Christy Santhosh and Padmanabhan Ananthan Sept 21 (Reuters) – The US FDA's staff reviewers did not raise major concerns about the accuracy and safety of Grail's blood test designed to detect more

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)